Merck KGaA's lung cancer drugs show promise in early-stage trials

FRANKFURT (Reuters) - Germany's Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients, potentially helping the company's efforts to find drug-industry partners to share further development costs.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news